The FDA Center on Tobacco Products Addresses to Optimize the Review Process

The FDA CTP announces it has made significant progress in addressing recommendations from the Reagan-Udall evaluation.

A new strategic plan is being developed, focusing on health equity, with proposed goals set to be issued this summer and the final plan to be released by December 2023.

Efforts to improve transparency and information sharing internally and externally are underway, including the creation of an operational strategy and the publication of tobacco product-related citizen petitions.

The review process for tobacco product applications is nearing completion, with 99% of submissions reviewed to date, and plans for stakeholder engagement through a public meeting.
Rules on menthol cigarettes, flavored cigars, and maximum nicotine levels are being finalized, and a policy unit is being established for overall policy coordination.

Enforcement actions against illegal tobacco products, particularly those appealing to youth, have been taken, including warning letters and civil money penalties.

Public education campaigns, such as "The Real Cost" and "Next Legends," are being developed based on scientific research and stakeholder input.

Efforts to optimize hiring processes, secure additional resources, and engage with stakeholders and federal partners are ongoing.

Regular updates on progress will be provided, and detailed information can be found on CTP's dedicated webpage.

References:

The Center for Tobacco Products (CTP) has made significant progress in implementing the recommendations from the Reagan-Udall Evaluation.